Global Diclofenac Sodium Sustained-release Tablets Market Growth 2026-2032

September 2026 | 120 pages | ID: G93B11EA61CFEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Diclofenac Sodium Sustained-release Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

United States market for Diclofenac Sodium Sustained-release Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Diclofenac Sodium Sustained-release Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Diclofenac Sodium Sustained-release Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Diclofenac Sodium Sustained-release Tablets players cover Hunan Warrant Pharmaceutical Co.,ltd., Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, Sinopharm Zhijun (SHENZHEN) Pingshan Pharmaceutical Co., Ltd., Zhejiang Deyer Pharmaceutical Co., Ltd., Nanjing Yiheng Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the “Diclofenac Sodium Sustained-release Tablets Industry Forecast” looks at past sales and reviews total world Diclofenac Sodium Sustained-release Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Diclofenac Sodium Sustained-release Tablets sales for 2026 through 2032. With Diclofenac Sodium Sustained-release Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diclofenac Sodium Sustained-release Tablets industry.

This Insight Report provides a comprehensive analysis of the global Diclofenac Sodium Sustained-release Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Diclofenac Sodium Sustained-release Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Diclofenac Sodium Sustained-release Tablets market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diclofenac Sodium Sustained-release Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diclofenac Sodium Sustained-release Tablets.

This report presents a comprehensive overview, market shares, and growth opportunities of Diclofenac Sodium Sustained-release Tablets market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • 75 mg Tablets
  • 100 mg Tablets
Segmentation by Application:
  • Hospital
  • Clinic
  • Other
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Hunan Warrant Pharmaceutical Co.,ltd.
  • Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
  • Sinopharm Zhijun (SHENZHEN) Pingshan Pharmaceutical Co., Ltd.
  • Zhejiang Deyer Pharmaceutical Co., Ltd.
  • Nanjing Yiheng Pharmaceutical Co., Ltd.
  • Shanghai Sine Pharmaceutical Laboratories Co.,Ltd.
  • Beijing Novartis Pharma Co., Ltd.
  • Dezhou Deyao Pharmaceutical Co., Ltd.
  • Zhuhai Rundu Pharmaceutical Co.,Ltd.
  • Novartis Pharma GmbH
  • Sichuan Huaxin Pharmaceutical Co., Ltd.
  • Lannett Company, Inc
  • Elam Pharma
Key Questions Addressed in this Report
  • What is the 10-year outlook for the global Diclofenac Sodium Sustained-release Tablets market?
  • What factors are driving Diclofenac Sodium Sustained-release Tablets market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Diclofenac Sodium Sustained-release Tablets market opportunities vary by end market size?
  • How does Diclofenac Sodium Sustained-release Tablets break out by Type, by Application?
1 SCOPE OF THE REPORT

  1.1 Market Introduction
  1.2 Years Considered
  1.3 Research Objectives
  1.4 Market Research Methodology
  1.5 Research Process and Data Source
  1.6 Economic Indicators
  1.7 Currency Considered
  1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

  2.1 World Market Overview
  2.1.1 Global Diclofenac Sodium Sustained-release Tablets Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Diclofenac Sodium Sustained-release Tablets by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Diclofenac Sodium Sustained-release Tablets by Country/Region, 2021, 2025 & 2032
  2.2 Diclofenac Sodium Sustained-release Tablets Segment by Type
  2.2.1 75 mg Tablets
  2.2.2 100 mg Tablets
  2.2.3 Diclofenac Sodium Sustained-release Tablets Sales by Type
  2.2.3.1 Global Diclofenac Sodium Sustained-release Tablets Sales Market Share by Type (2021-2026)
  2.2.3.2 Global Diclofenac Sodium Sustained-release Tablets Revenue and Market Share by Type (2021-2026)
  2.2.3.3 Global Diclofenac Sodium Sustained-release Tablets Sale Price by Type (2021-2026)
  2.3 Diclofenac Sodium Sustained-release Tablets Segment by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Other
  2.3.4 Diclofenac Sodium Sustained-release Tablets Sales by Application
  2.3.4.1 Global Diclofenac Sodium Sustained-release Tablets Sale Market Share by Application (2021-2026)
  2.3.4.2 Global Diclofenac Sodium Sustained-release Tablets Revenue and Market Share by Application (2021-2026)
  2.3.4.3 Global Diclofenac Sodium Sustained-release Tablets Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

  3.1 Global Diclofenac Sodium Sustained-release Tablets Breakdown Data by Company
  3.1.1 Global Diclofenac Sodium Sustained-release Tablets Annual Sales by Company (2021-2026)
  3.1.2 Global Diclofenac Sodium Sustained-release Tablets Sales Market Share by Company (2021-2026)
  3.2 Global Diclofenac Sodium Sustained-release Tablets Annual Revenue by Company (2021-2026)
  3.2.1 Global Diclofenac Sodium Sustained-release Tablets Revenue by Company (2021-2026)
  3.2.2 Global Diclofenac Sodium Sustained-release Tablets Revenue Market Share by Company (2021-2026)
  3.3 Global Diclofenac Sodium Sustained-release Tablets Sale Price by Company
  3.4 Key Manufacturers Diclofenac Sodium Sustained-release Tablets Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Diclofenac Sodium Sustained-release Tablets Product Location Distribution
  3.4.2 Players Diclofenac Sodium Sustained-release Tablets Products Offered
  3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
  3.6 New Products and Potential Entrants
  3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR DICLOFENAC SODIUM SUSTAINED-RELEASE TABLETS BY GEOGRAPHIC REGION

  4.1 World Historic Diclofenac Sodium Sustained-release Tablets Market Size by Geographic Region (2021-2026)
  4.1.1 Global Diclofenac Sodium Sustained-release Tablets Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Diclofenac Sodium Sustained-release Tablets Annual Revenue by Geographic Region (2021-2026)
  4.2 World Historic Diclofenac Sodium Sustained-release Tablets Market Size by Country/Region (2021-2026)
  4.2.1 Global Diclofenac Sodium Sustained-release Tablets Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Diclofenac Sodium Sustained-release Tablets Annual Revenue by Country/Region (2021-2026)
  4.3 Americas Diclofenac Sodium Sustained-release Tablets Sales Growth
  4.4 APAC Diclofenac Sodium Sustained-release Tablets Sales Growth
  4.5 Europe Diclofenac Sodium Sustained-release Tablets Sales Growth
  4.6 Middle East & Africa Diclofenac Sodium Sustained-release Tablets Sales Growth

5 AMERICAS

  5.1 Americas Diclofenac Sodium Sustained-release Tablets Sales by Country
  5.1.1 Americas Diclofenac Sodium Sustained-release Tablets Sales by Country (2021-2026)
  5.1.2 Americas Diclofenac Sodium Sustained-release Tablets Revenue by Country (2021-2026)
  5.2 Americas Diclofenac Sodium Sustained-release Tablets Sales by Type (2021-2026)
  5.3 Americas Diclofenac Sodium Sustained-release Tablets Sales by Application (2021-2026)
  5.4 United States
  5.5 Canada
  5.6 Mexico
  5.7 Brazil

6 APAC

  6.1 APAC Diclofenac Sodium Sustained-release Tablets Sales by Region
  6.1.1 APAC Diclofenac Sodium Sustained-release Tablets Sales by Region (2021-2026)
  6.1.2 APAC Diclofenac Sodium Sustained-release Tablets Revenue by Region (2021-2026)
  6.2 APAC Diclofenac Sodium Sustained-release Tablets Sales by Type (2021-2026)
  6.3 APAC Diclofenac Sodium Sustained-release Tablets Sales by Application (2021-2026)
  6.4 China
  6.5 Japan
  6.6 South Korea
  6.7 Southeast Asia
  6.8 India
  6.9 Australia
  6.10 China Taiwan

7 EUROPE

  7.1 Europe Diclofenac Sodium Sustained-release Tablets by Country
  7.1.1 Europe Diclofenac Sodium Sustained-release Tablets Sales by Country (2021-2026)
  7.1.2 Europe Diclofenac Sodium Sustained-release Tablets Revenue by Country (2021-2026)
  7.2 Europe Diclofenac Sodium Sustained-release Tablets Sales by Type (2021-2026)
  7.3 Europe Diclofenac Sodium Sustained-release Tablets Sales by Application (2021-2026)
  7.4 Germany
  7.5 France
  7.6 UK
  7.7 Italy
  7.8 Russia

8 MIDDLE EAST & AFRICA

  8.1 Middle East & Africa Diclofenac Sodium Sustained-release Tablets by Country
  8.1.1 Middle East & Africa Diclofenac Sodium Sustained-release Tablets Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Diclofenac Sodium Sustained-release Tablets Revenue by Country (2021-2026)
  8.2 Middle East & Africa Diclofenac Sodium Sustained-release Tablets Sales by Type (2021-2026)
  8.3 Middle East & Africa Diclofenac Sodium Sustained-release Tablets Sales by Application (2021-2026)
  8.4 Egypt
  8.5 South Africa
  8.6 Israel
  8.7 Turkey
  8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

  9.1 Market Drivers & Growth Opportunities
  9.2 Market Challenges & Risks
  9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

  10.1 Raw Material and Suppliers
  10.2 Manufacturing Cost Structure Analysis of Diclofenac Sodium Sustained-release Tablets
  10.3 Manufacturing Process Analysis of Diclofenac Sodium Sustained-release Tablets
  10.4 Industry Chain Structure of Diclofenac Sodium Sustained-release Tablets

11 MARKETING, DISTRIBUTORS AND CUSTOMER

  11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
  11.2 Diclofenac Sodium Sustained-release Tablets Distributors
  11.3 Diclofenac Sodium Sustained-release Tablets Customer

12 WORLD FORECAST REVIEW FOR DICLOFENAC SODIUM SUSTAINED-RELEASE TABLETS BY GEOGRAPHIC REGION

  12.1 Global Diclofenac Sodium Sustained-release Tablets Market Size Forecast by Region
  12.1.1 Global Diclofenac Sodium Sustained-release Tablets Forecast by Region (2027-2032)
  12.1.2 Global Diclofenac Sodium Sustained-release Tablets Annual Revenue Forecast by Region (2027-2032)
  12.2 Americas Forecast by Country (2027-2032)
  12.3 APAC Forecast by Region (2027-2032)
  12.4 Europe Forecast by Country (2027-2032)
  12.5 Middle East & Africa Forecast by Country (2027-2032)
  12.6 Global Diclofenac Sodium Sustained-release Tablets Forecast by Type (2027-2032)
  12.7 Global Diclofenac Sodium Sustained-release Tablets Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

  13.1 Hunan Warrant Pharmaceutical Co.,ltd.
  13.1.1 Hunan Warrant Pharmaceutical Co.,ltd. Company Information
  13.1.2 Hunan Warrant Pharmaceutical Co.,ltd. Diclofenac Sodium Sustained-release Tablets Product Portfolios and Specifications
  13.1.3 Hunan Warrant Pharmaceutical Co.,ltd. Diclofenac Sodium Sustained-release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Hunan Warrant Pharmaceutical Co.,ltd. Main Business Overview
  13.1.5 Hunan Warrant Pharmaceutical Co.,ltd. Latest Developments
  13.2 Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
  13.2.1 Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Company Information
  13.2.2 Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Diclofenac Sodium Sustained-release Tablets Product Portfolios and Specifications
  13.2.3 Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Diclofenac Sodium Sustained-release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Main Business Overview
  13.2.5 Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Latest Developments
  13.3 Sinopharm Zhijun (SHENZHEN) Pingshan Pharmaceutical Co., Ltd.
  13.3.1 Sinopharm Zhijun (SHENZHEN) Pingshan Pharmaceutical Co., Ltd. Company Information
  13.3.2 Sinopharm Zhijun (SHENZHEN) Pingshan Pharmaceutical Co., Ltd. Diclofenac Sodium Sustained-release Tablets Product Portfolios and Specifications
  13.3.3 Sinopharm Zhijun (SHENZHEN) Pingshan Pharmaceutical Co., Ltd. Diclofenac Sodium Sustained-release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Sinopharm Zhijun (SHENZHEN) Pingshan Pharmaceutical Co., Ltd. Main Business Overview
  13.3.5 Sinopharm Zhijun (SHENZHEN) Pingshan Pharmaceutical Co., Ltd. Latest Developments
  13.4 Zhejiang Deyer Pharmaceutical Co., Ltd.
  13.4.1 Zhejiang Deyer Pharmaceutical Co., Ltd. Company Information
  13.4.2 Zhejiang Deyer Pharmaceutical Co., Ltd. Diclofenac Sodium Sustained-release Tablets Product Portfolios and Specifications
  13.4.3 Zhejiang Deyer Pharmaceutical Co., Ltd. Diclofenac Sodium Sustained-release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Zhejiang Deyer Pharmaceutical Co., Ltd. Main Business Overview
  13.4.5 Zhejiang Deyer Pharmaceutical Co., Ltd. Latest Developments
  13.5 Nanjing Yiheng Pharmaceutical Co., Ltd.
  13.5.1 Nanjing Yiheng Pharmaceutical Co., Ltd. Company Information
  13.5.2 Nanjing Yiheng Pharmaceutical Co., Ltd. Diclofenac Sodium Sustained-release Tablets Product Portfolios and Specifications
  13.5.3 Nanjing Yiheng Pharmaceutical Co., Ltd. Diclofenac Sodium Sustained-release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Nanjing Yiheng Pharmaceutical Co., Ltd. Main Business Overview
  13.5.5 Nanjing Yiheng Pharmaceutical Co., Ltd. Latest Developments
  13.6 Shanghai Sine Pharmaceutical Laboratories Co.,Ltd.
  13.6.1 Shanghai Sine Pharmaceutical Laboratories Co.,Ltd. Company Information
  13.6.2 Shanghai Sine Pharmaceutical Laboratories Co.,Ltd. Diclofenac Sodium Sustained-release Tablets Product Portfolios and Specifications
  13.6.3 Shanghai Sine Pharmaceutical Laboratories Co.,Ltd. Diclofenac Sodium Sustained-release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Shanghai Sine Pharmaceutical Laboratories Co.,Ltd. Main Business Overview
  13.6.5 Shanghai Sine Pharmaceutical Laboratories Co.,Ltd. Latest Developments
  13.7 Beijing Novartis Pharma Co., Ltd.
  13.7.1 Beijing Novartis Pharma Co., Ltd. Company Information
  13.7.2 Beijing Novartis Pharma Co., Ltd. Diclofenac Sodium Sustained-release Tablets Product Portfolios and Specifications
  13.7.3 Beijing Novartis Pharma Co., Ltd. Diclofenac Sodium Sustained-release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Beijing Novartis Pharma Co., Ltd. Main Business Overview
  13.7.5 Beijing Novartis Pharma Co., Ltd. Latest Developments
  13.8 Dezhou Deyao Pharmaceutical Co., Ltd.
  13.8.1 Dezhou Deyao Pharmaceutical Co., Ltd. Company Information
  13.8.2 Dezhou Deyao Pharmaceutical Co., Ltd. Diclofenac Sodium Sustained-release Tablets Product Portfolios and Specifications
  13.8.3 Dezhou Deyao Pharmaceutical Co., Ltd. Diclofenac Sodium Sustained-release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Dezhou Deyao Pharmaceutical Co., Ltd. Main Business Overview
  13.8.5 Dezhou Deyao Pharmaceutical Co., Ltd. Latest Developments
  13.9 Zhuhai Rundu Pharmaceutical Co.,Ltd.
  13.9.1 Zhuhai Rundu Pharmaceutical Co.,Ltd. Company Information
  13.9.2 Zhuhai Rundu Pharmaceutical Co.,Ltd. Diclofenac Sodium Sustained-release Tablets Product Portfolios and Specifications
  13.9.3 Zhuhai Rundu Pharmaceutical Co.,Ltd. Diclofenac Sodium Sustained-release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Zhuhai Rundu Pharmaceutical Co.,Ltd. Main Business Overview
  13.9.5 Zhuhai Rundu Pharmaceutical Co.,Ltd. Latest Developments
  13.10 Novartis Pharma GmbH
  13.10.1 Novartis Pharma GmbH Company Information
  13.10.2 Novartis Pharma GmbH Diclofenac Sodium Sustained-release Tablets Product Portfolios and Specifications
  13.10.3 Novartis Pharma GmbH Diclofenac Sodium Sustained-release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 Novartis Pharma GmbH Main Business Overview
  13.10.5 Novartis Pharma GmbH Latest Developments
  13.11 Sichuan Huaxin Pharmaceutical Co., Ltd.
  13.11.1 Sichuan Huaxin Pharmaceutical Co., Ltd. Company Information
  13.11.2 Sichuan Huaxin Pharmaceutical Co., Ltd. Diclofenac Sodium Sustained-release Tablets Product Portfolios and Specifications
  13.11.3 Sichuan Huaxin Pharmaceutical Co., Ltd. Diclofenac Sodium Sustained-release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.11.4 Sichuan Huaxin Pharmaceutical Co., Ltd. Main Business Overview
  13.11.5 Sichuan Huaxin Pharmaceutical Co., Ltd. Latest Developments
  13.12 Lannett Company, Inc
  13.12.1 Lannett Company, Inc Company Information
  13.12.2 Lannett Company, Inc Diclofenac Sodium Sustained-release Tablets Product Portfolios and Specifications
  13.12.3 Lannett Company, Inc Diclofenac Sodium Sustained-release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.12.4 Lannett Company, Inc Main Business Overview
  13.12.5 Lannett Company, Inc Latest Developments
  13.13 Elam Pharma
  13.13.1 Elam Pharma Company Information
  13.13.2 Elam Pharma Diclofenac Sodium Sustained-release Tablets Product Portfolios and Specifications
  13.13.3 Elam Pharma Diclofenac Sodium Sustained-release Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.13.4 Elam Pharma Main Business Overview
  13.13.5 Elam Pharma Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Diclofenac Sodium Sustained-release Tablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Diclofenac Sodium Sustained-release Tablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 75 mg Tablets
Table 4. Major Players of 100 mg Tablets
Table 5. Global Diclofenac Sodium Sustained-release Tablets Sales by Type (2021-2026) & (K Units)
Table 6. Global Diclofenac Sodium Sustained-release Tablets Sales Market Share by Type (2021-2026)
Table 7. Global Diclofenac Sodium Sustained-release Tablets Revenue by Type (2021-2026) & ($ million)
Table 8. Global Diclofenac Sodium Sustained-release Tablets Revenue Market Share by Type (2021-2026)
Table 9. Global Diclofenac Sodium Sustained-release Tablets Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Diclofenac Sodium Sustained-release Tablets Sale by Application (2021-2026) & (K Units)
Table 11. Global Diclofenac Sodium Sustained-release Tablets Sale Market Share by Application (2021-2026)
Table 12. Global Diclofenac Sodium Sustained-release Tablets Revenue by Application (2021-2026) & ($ million)
Table 13. Global Diclofenac Sodium Sustained-release Tablets Revenue Market Share by Application (2021-2026)
Table 14. Global Diclofenac Sodium Sustained-release Tablets Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Diclofenac Sodium Sustained-release Tablets Sales by Company (2021-2026) & (K Units)
Table 16. Global Diclofenac Sodium Sustained-release Tablets Sales Market Share by Company (2021-2026)
Table 17. Global Diclofenac Sodium Sustained-release Tablets Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Diclofenac Sodium Sustained-release Tablets Revenue Market Share by Company (2021-2026)
Table 19. Global Diclofenac Sodium Sustained-release Tablets Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Diclofenac Sodium Sustained-release Tablets Producing Area Distribution and Sales Area
Table 21. Players Diclofenac Sodium Sustained-release Tablets Products Offered
Table 22. Diclofenac Sodium Sustained-release Tablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Diclofenac Sodium Sustained-release Tablets Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Diclofenac Sodium Sustained-release Tablets Sales Market Share Geographic Region (2021-2026)
Table 27. Global Diclofenac Sodium Sustained-release Tablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Diclofenac Sodium Sustained-release Tablets Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Diclofenac Sodium Sustained-release Tablets Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Diclofenac Sodium Sustained-release Tablets Sales Market Share by Country/Region (2021-2026)
Table 31. Global Diclofenac Sodium Sustained-release Tablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Diclofenac Sodium Sustained-release Tablets Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Diclofenac Sodium Sustained-release Tablets Sales by Country (2021-2026) & (K Units)
Table 34. Americas Diclofenac Sodium Sustained-release Tablets Sales Market Share by Country (2021-2026)
Table 35. Americas Diclofenac Sodium Sustained-release Tablets Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Diclofenac Sodium Sustained-release Tablets Sales by Type (2021-2026) & (K Units)
Table 37. Americas Diclofenac Sodium Sustained-release Tablets Sales by Application (2021-2026) & (K Units)
Table 38. APAC Diclofenac Sodium Sustained-release Tablets Sales by Region (2021-2026) & (K Units)
Table 39. APAC Diclofenac Sodium Sustained-release Tablets Sales Market Share by Region (2021-2026)
Table 40. APAC Diclofenac Sodium Sustained-release Tablets Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Diclofenac Sodium Sustained-release Tablets Sales by Type (2021-2026) & (K Units)
Table 42. APAC Diclofenac Sodium Sustained-release Tablets Sales by Application (2021-2026) & (K Units)
Table 43. Europe Diclofenac Sodium Sustained-release Tablets Sales by Country (2021-2026) & (K Units)
Table 44. Europe Diclofenac Sodium Sustained-release Tablets Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Diclofenac Sodium Sustained-release Tablets Sales by Type (2021-2026) & (K Units)
Table 46. Europe Diclofenac Sodium Sustained-release Tablets Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Diclofenac Sodium Sustained-release Tablets Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Diclofenac Sodium Sustained-release Tablets Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Diclofenac Sodium Sustained-release Tablets Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Diclofenac Sodium Sustained-release Tablets Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Diclofenac Sodium Sustained-release Tablets
Table 52. Key Market Challenges & Risks of Diclofenac Sodium Sustained-release Tablets
Table 53. Key Industry Trends of Diclofenac Sodium Sustained-release Tablets
Table 54. Diclofenac Sodium Sustained-release Tablets Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Diclofenac Sodium Sustained-release Tablets Distributors List
Table 57. Diclofenac Sodium Sustained-release Tablets Customer List
Table 58. Global Diclofenac Sodium Sustained-release Tablets Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Diclofenac Sodium Sustained-release Tablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Diclofenac Sodium Sustained-release Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Diclofenac Sodium Sustained-release Tablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Diclofenac Sodium Sustained-release Tablets Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Diclofenac Sodium Sustained-release Tablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Diclofenac Sodium Sustained-release Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Diclofenac Sodium Sustained-release Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Diclofenac Sodium Sustained-release Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Diclofenac Sodium Sustained-release Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Diclofenac Sodium Sustained-release Tablets Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Diclofenac Sodium Sustained-release Tablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Diclofenac Sodium Sustained-release Tablets Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Diclofenac Sodium Sustained-release Tablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Hunan Warrant Pharmaceutical Co.,ltd. Basic Information, Diclofenac Sodium Sustained-release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 73. Hunan Warrant Pharmaceutical Co.,ltd. Diclofenac Sodium Sustained-release Tablets Product Portfolios and Specifications
Table 74. Hunan Warrant Pharmaceutical Co.,ltd. Diclofenac Sodium Sustained-release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Hunan Warrant Pharmaceutical Co.,ltd. Main Business
Table 76. Hunan Warrant Pharmaceutical Co.,ltd. Latest Developments
Table 77. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Basic Information, Diclofenac Sodium Sustained-release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 78. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Diclofenac Sodium Sustained-release Tablets Product Portfolios and Specifications
Table 79. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Diclofenac Sodium Sustained-release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Main Business
Table 81. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Latest Developments
Table 82. Sinopharm Zhijun (SHENZHEN) Pingshan Pharmaceutical Co., Ltd. Basic Information, Diclofenac Sodium Sustained-release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 83. Sinopharm Zhijun (SHENZHEN) Pingshan Pharmaceutical Co., Ltd. Diclofenac Sodium Sustained-release Tablets Product Portfolios and Specifications
Table 84. Sinopharm Zhijun (SHENZHEN) Pingshan Pharmaceutical Co., Ltd. Diclofenac Sodium Sustained-release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Sinopharm Zhijun (SHENZHEN) Pingshan Pharmaceutical Co., Ltd. Main Business
Table 86. Sinopharm Zhijun (SHENZHEN) Pingshan Pharmaceutical Co., Ltd. Latest Developments
Table 87. Zhejiang Deyer Pharmaceutical Co., Ltd. Basic Information, Diclofenac Sodium Sustained-release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 88. Zhejiang Deyer Pharmaceutical Co., Ltd. Diclofenac Sodium Sustained-release Tablets Product Portfolios and Specifications
Table 89. Zhejiang Deyer Pharmaceutical Co., Ltd. Diclofenac Sodium Sustained-release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Zhejiang Deyer Pharmaceutical Co., Ltd. Main Business
Table 91. Zhejiang Deyer Pharmaceutical Co., Ltd. Latest Developments
Table 92. Nanjing Yiheng Pharmaceutical Co., Ltd. Basic Information, Diclofenac Sodium Sustained-release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 93. Nanjing Yiheng Pharmaceutical Co., Ltd. Diclofenac Sodium Sustained-release Tablets Product Portfolios and Specifications
Table 94. Nanjing Yiheng Pharmaceutical Co., Ltd. Diclofenac Sodium Sustained-release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Nanjing Yiheng Pharmaceutical Co., Ltd. Main Business
Table 96. Nanjing Yiheng Pharmaceutical Co., Ltd. Latest Developments
Table 97. Shanghai Sine Pharmaceutical Laboratories Co.,Ltd. Basic Information, Diclofenac Sodium Sustained-release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 98. Shanghai Sine Pharmaceutical Laboratories Co.,Ltd. Diclofenac Sodium Sustained-release Tablets Product Portfolios and Specifications
Table 99. Shanghai Sine Pharmaceutical Laboratories Co.,Ltd. Diclofenac Sodium Sustained-release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Shanghai Sine Pharmaceutical Laboratories Co.,Ltd. Main Business
Table 101. Shanghai Sine Pharmaceutical Laboratories Co.,Ltd. Latest Developments
Table 102. Beijing Novartis Pharma Co., Ltd. Basic Information, Diclofenac Sodium Sustained-release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 103. Beijing Novartis Pharma Co., Ltd. Diclofenac Sodium Sustained-release Tablets Product Portfolios and Specifications
Table 104. Beijing Novartis Pharma Co., Ltd. Diclofenac Sodium Sustained-release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Beijing Novartis Pharma Co., Ltd. Main Business
Table 106. Beijing Novartis Pharma Co., Ltd. Latest Developments
Table 107. Dezhou Deyao Pharmaceutical Co., Ltd. Basic Information, Diclofenac Sodium Sustained-release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 108. Dezhou Deyao Pharmaceutical Co., Ltd. Diclofenac Sodium Sustained-release Tablets Product Portfolios and Specifications
Table 109. Dezhou Deyao Pharmaceutical Co., Ltd. Diclofenac Sodium Sustained-release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Dezhou Deyao Pharmaceutical Co., Ltd. Main Business
Table 111. Dezhou Deyao Pharmaceutical Co., Ltd. Latest Developments
Table 112. Zhuhai Rundu Pharmaceutical Co.,Ltd. Basic Information, Diclofenac Sodium Sustained-release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 113. Zhuhai Rundu Pharmaceutical Co.,Ltd. Diclofenac Sodium Sustained-release Tablets Product Portfolios and Specifications
Table 114. Zhuhai Rundu Pharmaceutical Co.,Ltd. Diclofenac Sodium Sustained-release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Zhuhai Rundu Pharmaceutical Co.,Ltd. Main Business
Table 116. Zhuhai Rundu Pharmaceutical Co.,Ltd. Latest Developments
Table 117. Novartis Pharma GmbH Basic Information, Diclofenac Sodium Sustained-release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 118. Novartis Pharma GmbH Diclofenac Sodium Sustained-release Tablets Product Portfolios and Specifications
Table 119. Novartis Pharma GmbH Diclofenac Sodium Sustained-release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Novartis Pharma GmbH Main Business
Table 121. Novartis Pharma GmbH Latest Developments
Table 122. Sichuan Huaxin Pharmaceutical Co., Ltd. Basic Information, Diclofenac Sodium Sustained-release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 123. Sichuan Huaxin Pharmaceutical Co., Ltd. Diclofenac Sodium Sustained-release Tablets Product Portfolios and Specifications
Table 124. Sichuan Huaxin Pharmaceutical Co., Ltd. Diclofenac Sodium Sustained-release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Sichuan Huaxin Pharmaceutical Co., Ltd. Main Business
Table 126. Sichuan Huaxin Pharmaceutical Co., Ltd. Latest Developments
Table 127. Lannett Company, Inc Basic Information, Diclofenac Sodium Sustained-release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 128. Lannett Company, Inc Diclofenac Sodium Sustained-release Tablets Product Portfolios and Specifications
Table 129. Lannett Company, Inc Diclofenac Sodium Sustained-release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Lannett Company, Inc Main Business
Table 131. Lannett Company, Inc Latest Developments
Table 132. Elam Pharma Basic Information, Diclofenac Sodium Sustained-release Tablets Manufacturing Base, Sales Area and Its Competitors
Table 133. Elam Pharma Diclofenac Sodium Sustained-release Tablets Product Portfolios and Specifications
Table 134. Elam Pharma Diclofenac Sodium Sustained-release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Elam Pharma Main Business
Table 136. Elam Pharma Latest Developments

LIST OF FIGURES

Figure 1. Picture of Diclofenac Sodium Sustained-release Tablets
Figure 2. Diclofenac Sodium Sustained-release Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Diclofenac Sodium Sustained-release Tablets Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Diclofenac Sodium Sustained-release Tablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Diclofenac Sodium Sustained-release Tablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Diclofenac Sodium Sustained-release Tablets Sales Market Share by Country/Region (2025)
Figure 10. Diclofenac Sodium Sustained-release Tablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 75 mg Tablets
Figure 12. Product Picture of 100 mg Tablets
Figure 13. Global Diclofenac Sodium Sustained-release Tablets Sales Market Share by Type in 2026
Figure 14. Global Diclofenac Sodium Sustained-release Tablets Revenue Market Share by Type (2021-2026)
Figure 15. Diclofenac Sodium Sustained-release Tablets Consumed in Hospital
Figure 16. Global Diclofenac Sodium Sustained-release Tablets Market: Hospital (2021-2026) & (K Units)
Figure 17. Diclofenac Sodium Sustained-release Tablets Consumed in Clinic
Figure 18. Global Diclofenac Sodium Sustained-release Tablets Market: Clinic (2021-2026) & (K Units)
Figure 19. Diclofenac Sodium Sustained-release Tablets Consumed in Other
Figure 20. Global Diclofenac Sodium Sustained-release Tablets Market: Other (2021-2026) & (K Units)
Figure 21. Global Diclofenac Sodium Sustained-release Tablets Sale Market Share by Application (2025)
Figure 22. Global Diclofenac Sodium Sustained-release Tablets Revenue Market Share by Application in 2026
Figure 23. Diclofenac Sodium Sustained-release Tablets Sales by Company in 2026 (K Units)
Figure 24. Global Diclofenac Sodium Sustained-release Tablets Sales Market Share by Company in 2026
Figure 25. Diclofenac Sodium Sustained-release Tablets Revenue by Company in 2026 ($ millions)
Figure 26. Global Diclofenac Sodium Sustained-release Tablets Revenue Market Share by Company in 2026
Figure 27. Global Diclofenac Sodium Sustained-release Tablets Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Diclofenac Sodium Sustained-release Tablets Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Diclofenac Sodium Sustained-release Tablets Sales 2021-2026 (K Units)
Figure 30. Americas Diclofenac Sodium Sustained-release Tablets Revenue 2021-2026 ($ millions)
Figure 31. APAC Diclofenac Sodium Sustained-release Tablets Sales 2021-2026 (K Units)
Figure 32. APAC Diclofenac Sodium Sustained-release Tablets Revenue 2021-2026 ($ millions)
Figure 33. Europe Diclofenac Sodium Sustained-release Tablets Sales 2021-2026 (K Units)
Figure 34. Europe Diclofenac Sodium Sustained-release Tablets Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Diclofenac Sodium Sustained-release Tablets Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Diclofenac Sodium Sustained-release Tablets Revenue 2021-2026 ($ millions)
Figure 37. Americas Diclofenac Sodium Sustained-release Tablets Sales Market Share by Country in 2026
Figure 38. Americas Diclofenac Sodium Sustained-release Tablets Revenue Market Share by Country (2021-2026)
Figure 39. Americas Diclofenac Sodium Sustained-release Tablets Sales Market Share by Type (2021-2026)
Figure 40. Americas Diclofenac Sodium Sustained-release Tablets Sales Market Share by Application (2021-2026)
Figure 41. United States Diclofenac Sodium Sustained-release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Diclofenac Sodium Sustained-release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Diclofenac Sodium Sustained-release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Diclofenac Sodium Sustained-release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Diclofenac Sodium Sustained-release Tablets Sales Market Share by Region in 2026
Figure 46. APAC Diclofenac Sodium Sustained-release Tablets Revenue Market Share by Region (2021-2026)
Figure 47. APAC Diclofenac Sodium Sustained-release Tablets Sales Market Share by Type (2021-2026)
Figure 48. APAC Diclofenac Sodium Sustained-release Tablets Sales Market Share by Application (2021-2026)
Figure 49. China Diclofenac Sodium Sustained-release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Diclofenac Sodium Sustained-release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Diclofenac Sodium Sustained-release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Diclofenac Sodium Sustained-release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 53. India Diclofenac Sodium Sustained-release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Diclofenac Sodium Sustained-release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Diclofenac Sodium Sustained-release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Diclofenac Sodium Sustained-release Tablets Sales Market Share by Country in 2026
Figure 57. Europe Diclofenac Sodium Sustained-release Tablets Revenue Market Share by Country (2021-2026)
Figure 58. Europe Diclofenac Sodium Sustained-release Tablets Sales Market Share by Type (2021-2026)
Figure 59. Europe Diclofenac Sodium Sustained-release Tablets Sales Market Share by Application (2021-2026)
Figure 60. Germany Diclofenac Sodium Sustained-release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 61. France Diclofenac Sodium Sustained-release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Diclofenac Sodium Sustained-release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Diclofenac Sodium Sustained-release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Diclofenac Sodium Sustained-release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Diclofenac Sodium Sustained-release Tablets Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Diclofenac Sodium Sustained-release Tablets Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Diclofenac Sodium Sustained-release Tablets Sales Market Share by Application (2021-2026)
Figure 68. Egypt Diclofenac Sodium Sustained-release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Diclofenac Sodium Sustained-release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Diclofenac Sodium Sustained-release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Diclofenac Sodium Sustained-release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Diclofenac Sodium Sustained-release Tablets Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Diclofenac Sodium Sustained-release Tablets in 2026
Figure 74. Manufacturing Process Analysis of Diclofenac Sodium Sustained-release Tablets
Figure 75. Industry Chain Structure of Diclofenac Sodium Sustained-release Tablets
Figure 76. Channels of Distribution
Figure 77. Global Diclofenac Sodium Sustained-release Tablets Sales Market Forecast by Region (2027-2032)
Figure 78. Global Diclofenac Sodium Sustained-release Tablets Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Diclofenac Sodium Sustained-release Tablets Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Diclofenac Sodium Sustained-release Tablets Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Diclofenac Sodium Sustained-release Tablets Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Diclofenac Sodium Sustained-release Tablets Revenue Market Share Forecast by Application (2027-2032)


More Publications